These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 26932897)
1. Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis. Lee CM; Lee DH; Ahn BK; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N J Neurogastroenterol Motil; 2016 Jul; 22(3):444-51. PubMed ID: 26932897 [TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Uncertainties and Controversies. Wang Z; Bonella F; Li W; Boerner EB; Guo Q; Kong X; Zhang X; Costabel U; Kreuter M Respiration; 2018; 96(6):571-587. PubMed ID: 30308515 [TBL] [Abstract][Full Text] [Related]
3. Could prominent airway-centered fibroblast foci in lung biopsies predict underlying chronic microaspiration in idiopathic pulmonary fibrosis patients? Bois MC; Hu X; Ryu JH; Yi ES Hum Pathol; 2016 Jul; 53():1-7. PubMed ID: 26980038 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis: A Population-Based Cohort Study. Tran T; Assayag D; Ernst P; Suissa S Chest; 2021 Feb; 159(2):673-682. PubMed ID: 32882251 [TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal reflux disease and patterns of reflux in patients with idiopathic pulmonary fibrosis using hypopharyngeal multichannel intraluminal impedance. Hoppo T; Komatsu Y; Jobe BA Dis Esophagus; 2014 Aug; 27(6):530-7. PubMed ID: 23107023 [TBL] [Abstract][Full Text] [Related]
6. [The relationship between idiopathic pulmonary fibrosis and gastroesophageal reflux disease]. Qi J; Shang S; Li Z; Kang J; Kong L Zhonghua Nei Ke Za Zhi; 2015 Aug; 54(8):695-8. PubMed ID: 26674625 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis. Bédard Méthot D; Leblanc É; Lacasse Y Chest; 2019 Jan; 155(1):33-43. PubMed ID: 30120950 [TBL] [Abstract][Full Text] [Related]
8. Elucidating shared biomarkers in gastroesophageal reflux disease and idiopathic pulmonary fibrosis: insights into novel therapeutic targets and the role of angelicae sinensis radix. Wu X; Xiao X; Fang H; He C; Wang H; Wang M; Lan P; Wang F; Du Q; Yang H Front Pharmacol; 2024; 15():1348708. PubMed ID: 38414734 [No Abstract] [Full Text] [Related]
9. Idiopathic pulmonary fibrosis and GERD: links and risks. Ghisa M; Marinelli C; Savarino V; Savarino E Ther Clin Risk Manag; 2019; 15():1081-1093. PubMed ID: 31564886 [TBL] [Abstract][Full Text] [Related]
10. The Role of Gastroesophageal Reflux and Microaspiration in Idiopathic Pulmonary Fibrosis. Lee JS Clin Pulm Med; 2014 Mar; 21(2):81-85. PubMed ID: 24729673 [TBL] [Abstract][Full Text] [Related]
11. The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis. Gao F; Hobson AR; Shang ZM; Pei YX; Gao Y; Wang JX; Huang WN BMC Gastroenterol; 2015 Feb; 15():26. PubMed ID: 25881023 [TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis. Chen CH; Lin CL; Kao CH Osteoporos Int; 2016 Jun; 27(6):2117-26. PubMed ID: 26860609 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic pulmonary fibrosis: how often is it really idiopathic? Patti MG; Tedesco P; Golden J; Hays S; Hoopes C; Meneghetti A; Damani T; Way LW J Gastrointest Surg; 2005 Nov; 9(8):1053-6; discussion 1056-8. PubMed ID: 16269375 [TBL] [Abstract][Full Text] [Related]
14. Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study. Baqir M; Vasirreddy A; Vu AN; Moua T; Chamberlain AM; Frank RD; Ryu JH Respir Med; 2021 Mar; 178():106309. PubMed ID: 33517156 [TBL] [Abstract][Full Text] [Related]
15. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation. Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505 [TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited. Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425 [TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients. Gavini S; Finn RT; Lo WK; Goldberg HJ; Burakoff R; Feldman N; Chan WW Neurogastroenterol Motil; 2015 Sep; 27(9):1326-32. PubMed ID: 26176338 [TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? Ruaro B; Pozzan R; Confalonieri P; Tavano S; Hughes M; Matucci Cerinic M; Baratella E; Zanatta E; Lerda S; Geri P; Confalonieri M; Salton F Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015181 [TBL] [Abstract][Full Text] [Related]